Published in Ann Clin Psychiatry on December 12, 2006
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image (2008) 1.11
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry (2001) 0.98
Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res (2008) 0.84
High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. Neural Plast (2010) 0.76
Comorbidity between obsessive-compulsive disorder and body dysmorphic disorder: prevalence, explanatory theories, and clinical characterization. Neuropsychiatr Dis Treat (2015) 0.75
Pharmacotherapy for Body Dysmorphic Disorder. Psychiatr Ann (2010) 0.75
Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial. Am J Psychiatry (2016) 0.75
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull (1997) 3.84
Body dysmorphic disorder. A survey of fifty cases. Br J Psychiatry (1996) 3.51
Gender differences in body dysmorphic disorder. J Nerv Ment Dis (1997) 2.77
A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry (2002) 2.70
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry (1999) 2.50
The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry (2000) 2.29
Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics (2002) 1.99
Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis (2000) 1.67
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58
The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med (2006) 1.55
Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol (1997) 1.40
Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry (1998) 1.40
Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach. CNS Spectr (2002) 1.40
An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry (2003) 1.33
Psychosis in body dysmorphic disorder. J Psychiatr Res (2004) 1.33
Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry (2001) 1.27
Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry (2005) 1.20
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. J Clin Psychiatry (2001) 1.18
Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry (1998) 1.18
Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis (1996) 1.16
Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics (2005) 1.15
Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiatry (1999) 1.13
A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr (2002) 1.12
Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol (1996) 1.08
Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder. Psychiatr Q (2004) 1.00
A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. J Clin Psychiatry (2001) 0.96
Body dysmorphic disorder in patients with anorexia nervosa: prevalence, clinical features, and delusionality of body image. Int J Eat Disord (2002) 0.94
The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry (1996) 0.94
Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol (1994) 0.92
A retrospective follow-up study of body dysmorphic disorder. Compr Psychiatry (2005) 0.90
Body dysmorphic disorder. Psychiatr Clin North Am (2000) 0.88
Olanzapine augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry (2005) 0.87
The Collaborative Longitudinal Personality Disorders Study (CLPS): overview and implications. J Pers Disord (2005) 3.51
Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics (2005) 2.13
Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years. Psychol Med (2005) 1.97
Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J Consult Clin Psychol (2004) 1.96
Mechanisms of behavior change in alcoholics anonymous: does Alcoholics Anonymous lead to better alcohol use outcomes by reducing depression symptoms? Addiction (2010) 1.86
The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry (2006) 1.57
Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry (2005) 1.49
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Two-year prospective naturalistic study of remission from major depressive disorder as a function of personality disorder comorbidity. J Consult Clin Psychol (2005) 1.41
Spirituality in recovery: a lagged mediational analysis of alcoholics anonymous' principal theoretical mechanism of behavior change. Alcohol Clin Exp Res (2010) 1.40
Prospective assessment of treatment use by patients with personality disorders. Psychiatr Serv (2006) 1.37
Associations in the course of personality disorders and Axis I disorders over time. J Abnorm Psychol (2004) 1.37
Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry (2006) 1.34
Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry (2006) 1.33
Recent life events preceding suicide attempts in a personality disorder sample: findings from the collaborative longitudinal personality disorders study. J Consult Clin Psychol (2005) 1.30
Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry (2005) 1.24
Association between social influences and drinking outcomes across three years. J Stud Alcohol Drugs (2012) 1.22
Surgical and minimally invasive cosmetic procedures among persons with body dysmorphic disorder. Ann Plast Surg (2010) 1.17
Natural course of bulimia nervosa and of eating disorder not otherwise specified: 5-year prospective study of remissions, relapses, and the effects of personality disorder psychopathology. J Clin Psychiatry (2007) 1.16
Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics (2005) 1.15
A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry (2006) 1.14
Factor structure and stability of the Anxiety Sensitivity Index in a longitudinal study of anxiety disorder patients. Behav Res Ther (2004) 1.11
Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. J Addict Dis (2005) 1.11
Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients. J Nerv Ment Dis (2006) 1.09
Changes in cigarette consumption and drinking outcomes: findings from Project MATCH. J Subst Abuse Treat (2005) 1.08
Clinical features of body dysmorphic disorder in adolescents and adults. Psychiatry Res (2006) 1.07
Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image (2005) 1.05
The natural course of bulimia nervosa and eating disorder not otherwise specified is not influenced by personality disorders. Int J Eat Disord (2003) 1.04
Kickbacks from helping others: health and recovery. Recent Dev Alcohol (2008) 1.03
Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord (2004) 1.03
Influence of religiosity on 12-step participation and treatment response among substance-dependent adolescents. J Stud Alcohol Drugs (2011) 1.03
Impact of helping behaviors on the course of substance-use disorders in individuals with body dysmorphic disorder. J Stud Alcohol Drugs (2007) 1.02
Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance. Int J Eat Disord (2006) 1.00
Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry (2005) 0.99
Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry (2004) 0.99
Negative affect, relapse, and Alcoholics Anonymous (AA): does AA work by reducing anger? J Stud Alcohol Drugs (2010) 0.96
Weight concerns in individuals with body dysmorphic disorder. Eat Behav (2006) 0.96
Childhood abuse and neglect in body dysmorphic disorder. Child Abuse Negl (2006) 0.94
Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders. Depress Anxiety (2007) 0.94
Pathological skin picking in individuals with body dysmorphic disorder. Gen Hosp Psychiatry (2006) 0.92
Tanning in body dysmorphic disorder. Psychiatr Q (2006) 0.92
Validation of the Preschool and Early Childhood Functional Assessment Scale (PECFAS). J Child Fam Stud (1999) 0.92
Age at onset and clinical correlates in body dysmorphic disorder. Compr Psychiatry (2013) 0.91
Clarifying the convergence between obsessive compulsive personality disorder criteria and obsessive compulsive disorder. J Pers Disord (2006) 0.90
Timevarying predictors of smoking cessation among individuals in treatment for alcohol abuse and dependence: findings from Project MATCH. Alcohol Alcohol (2007) 0.89
Body dysmorphic disorder and social phobia: cross-sectional and prospective data. Depress Anxiety (2006) 0.88
The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. Child Adolesc Psychiatry Ment Health (2009) 0.87
12-Step Therapy and Women with and without Social Phobia: A Study of the Effectiveness of 12-Step Therapy to Facilitate AA Engagement. Alcohol Treat Q (2010) 0.87
Smoking initiation among nonsmokers during and following treatment for alcohol use disorders. J Subst Abuse Treat (2004) 0.87
Predictors of remission from body dysmorphic disorder: a prospective study. J Nerv Ment Dis (2005) 0.87
Positive childhood experiences: resilience and recovery from personality disorder in early adulthood. J Clin Psychiatry (2007) 0.86
Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder. J Affect Disord (2006) 0.86
Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry (2006) 0.85
Addiction and "Generation Me:" Narcissistic and Prosocial Behaviors of Adolescents with Substance Dependency Disorder in Comparison to Normative Adolescents. Alcohol Treat Q (2012) 0.85
A prospective pilot study of levetiracetam for body dysmorphic disorder. CNS Spectr (2009) 0.85
Effects of personality disorders on functioning and well-being in major depressive disorder. J Psychiatr Pract (2005) 0.84
Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry (2007) 0.84
Olfactory reference syndrome: demographic and clinical features of imagined body odor. Gen Hosp Psychiatry (2011) 0.84
A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder. Ann Clin Psychiatry (2007) 0.84
Inner-City Youth Development Organizations: Strengthening Programs for Adolescent Girls. J Early Adolesc (2000) 0.83
Environmental support for older and younger pilots' comprehension of air traffic control information. J Gerontol B Psychol Sci Soc Sci (2005) 0.83
Mental health treatment received by primary care patients with posttraumatic stress disorder. J Clin Psychiatry (2003) 0.83
The relationship between body dysmorphic disorder behaviors and the acquired capability for suicide. Suicide Life Threat Behav (2012) 0.83
A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder. J Psychiatr Res (2012) 0.82
Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders. J Subst Abuse Treat (2011) 0.81
Occupational functioning and impairment in adults with body dysmorphic disorder. Compr Psychiatry (2008) 0.81
Stressful life events predict eating disorder relapse following remission: six-year prospective outcomes. Int J Eat Disord (2011) 0.81
Psychometric characteristics of the Mobility Inventory in a longitudinal study of anxiety disorders: replicating and exploring a three component solution. J Anxiety Disord (2006) 0.81
Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders. Alcohol Clin Exp Res (2005) 0.80
The Role of Religiousness on Substance-Use Disorder Treatment Outcomes: A Comparison of Black and White Adolescents. J Soc Social Work Res (2012) 0.79
Youth Functioning and Experiences in Inner-City After-School Programs Among Age, Gender, and Race Groups. J Child Fam Stud (2001) 0.78
Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project. Prim Care Companion J Clin Psychiatry (2010) 0.78
Social functioning in body dysmorphic disorder: assessment considerations. Psychiatr Q (2006) 0.76
Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder. J Nerv Ment Dis (2013) 0.75
Interactions of borderline personality disorder and anxiety disorders over 10 years. J Clin Psychiatry (2015) 0.75
Body dysmorphic disorder and art background. Am J Psychiatry (2004) 0.75
Cued panic attacks in body dysmorphic disorder. J Psychiatr Pract (2013) 0.75